Zareh Zurabyan, head of the Americas division at eLabNext, joins us to discuss how the company has integrated generative AI workflows into their digital notebook solution for scientists. He addressed some of the main challenges hindering wider AI adoption in biotech, particularly privacy concerns related to data handling. We also explored Zareh’s journey to becoming an investor and the trends he’s most excited about in the biotech sector.